Açık Akademik Arşiv Sistemi

Early Switch to Mammalian Target of Rapamycin Inhibitors Is a Sustainable Treatment Approach in Renal Transplant Recipients: 7-Year Results

Early Switch to Mammalian Target of Rapamycin Inhibitors Is a Sustainable Treatment Approach in Renal Transplant Recipients: 7-Year Results

Dheir, Hamad
URI: https://doi.org/10.1016/j.transproceed.2019.01.098
https://hdl.handle.net/20.500.12619/66029
Date: 2019

Abstract:

Conclusion. Switching to m-TORi in the early posttransplant period is a safe and sustainable treatment approach.

Show full item record

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)